FI47096C - Process for the preparation of tert-butyl ester of therapeutically active alpha- (3-indolyl) lower aliphatic acids. - Google Patents

Process for the preparation of tert-butyl ester of therapeutically active alpha- (3-indolyl) lower aliphatic acids.

Info

Publication number
FI47096C
FI47096C FI256870A FI256870A FI47096C FI 47096 C FI47096 C FI 47096C FI 256870 A FI256870 A FI 256870A FI 256870 A FI256870 A FI 256870A FI 47096 C FI47096 C FI 47096C
Authority
FI
Finland
Prior art keywords
indolyl
tert
preparation
butyl ester
therapeutically active
Prior art date
Application number
FI256870A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI47096B (en
Inventor
George Gal
Sletzinger
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI47096B publication Critical patent/FI47096B/fi
Application granted granted Critical
Publication of FI47096C publication Critical patent/FI47096C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/281-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/36Oxygen atoms in position 3, e.g. adrenochrome

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI256870A 1963-02-01 1970-09-21 Process for the preparation of tert-butyl ester of therapeutically active alpha- (3-indolyl) lower aliphatic acids. FI47096C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25564263A 1963-02-01 1963-02-01

Publications (2)

Publication Number Publication Date
FI47096B FI47096B (en) 1973-05-31
FI47096C true FI47096C (en) 1973-09-10

Family

ID=22969254

Family Applications (9)

Application Number Title Priority Date Filing Date
FI16964A FI46955C (en) 1963-02-01 1964-01-29 Process for the preparation of therapeutically active 1-p-chlorobenzoyl-2-lower alkyl-5-lower alkoxy-3-indolylacetic acid
FI257170A FI47098C (en) 1963-02-01 1970-09-21 Process for the preparation of 1-p-chlorobenzoyl-2-methyl-5-methoxy-3-indolylacetaldehyde having an anti-inflammatory, antipyretic and analgesic effect.
FI257570A FI47101C (en) 1963-02-01 1970-09-21 Process for the preparation of therapeutically active alpha- (3-indolyl) -lower aliphatic acids.
FI702570A FI47097C (en) 1963-02-01 1970-09-21 Process for the preparation of therapeutically effective 1-p-chlorobenzoyl-2-methyl-5-methoxy-3-indolylacetic acid.
FI257370A FI47185C (en) 1963-02-01 1970-09-21 Process for the preparation of 1-p-chlorobenzoyl-2-methyl-5-methoxy-indole-3-ethanol with anti-inflammatory and antipyretic action.
FI256870A FI47096C (en) 1963-02-01 1970-09-21 Process for the preparation of tert-butyl ester of therapeutically active alpha- (3-indolyl) lower aliphatic acids.
FI257470A FI47100C (en) 1963-02-01 1970-09-21 Process for the preparation of therapeutically active 1-p-chlorobenzoyl-2-lower-alkyl-5-lower-alkoxy-3-indolyl-acetic acid.
FI257270A FI47099C (en) 1963-02-01 1970-09-21 A process for preparing 1-p-chlorobenzoyl-2-methyl-5-methoxy-3-indolylacetic acid having anti-inflammatory, antipyretic and analgesic activity.
FI257070A FI47097B (en) 1963-02-01 1970-09-21

Family Applications Before (5)

Application Number Title Priority Date Filing Date
FI16964A FI46955C (en) 1963-02-01 1964-01-29 Process for the preparation of therapeutically active 1-p-chlorobenzoyl-2-lower alkyl-5-lower alkoxy-3-indolylacetic acid
FI257170A FI47098C (en) 1963-02-01 1970-09-21 Process for the preparation of 1-p-chlorobenzoyl-2-methyl-5-methoxy-3-indolylacetaldehyde having an anti-inflammatory, antipyretic and analgesic effect.
FI257570A FI47101C (en) 1963-02-01 1970-09-21 Process for the preparation of therapeutically active alpha- (3-indolyl) -lower aliphatic acids.
FI702570A FI47097C (en) 1963-02-01 1970-09-21 Process for the preparation of therapeutically effective 1-p-chlorobenzoyl-2-methyl-5-methoxy-3-indolylacetic acid.
FI257370A FI47185C (en) 1963-02-01 1970-09-21 Process for the preparation of 1-p-chlorobenzoyl-2-methyl-5-methoxy-indole-3-ethanol with anti-inflammatory and antipyretic action.

Family Applications After (3)

Application Number Title Priority Date Filing Date
FI257470A FI47100C (en) 1963-02-01 1970-09-21 Process for the preparation of therapeutically active 1-p-chlorobenzoyl-2-lower-alkyl-5-lower-alkoxy-3-indolyl-acetic acid.
FI257270A FI47099C (en) 1963-02-01 1970-09-21 A process for preparing 1-p-chlorobenzoyl-2-methyl-5-methoxy-3-indolylacetic acid having anti-inflammatory, antipyretic and analgesic activity.
FI257070A FI47097B (en) 1963-02-01 1970-09-21

Country Status (11)

Country Link
AT (1) AT277992B (en)
BE (1) BE643268A (en)
BR (1) BR6456479D0 (en)
CH (16) CH466286A (en)
DE (16) DE1695492A1 (en)
DK (11) DK112238B (en)
FI (9) FI46955C (en)
FR (1) FR1559559A (en)
GB (13) GB1050730A (en)
NL (1) NL6400813A (en)
SE (12) SE317975B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU163233B (en) * 1970-07-31 1973-07-28
EP0347776B2 (en) * 1988-06-21 2002-07-10 Vita Zahnfabrik H. Rauter GmbH & Co. KG Dispersed ceramic material
GB9518994D0 (en) * 1995-09-16 1995-11-15 Agrevo Uk Ltd Fungicides

Also Published As

Publication number Publication date
DE1695488A1 (en) 1970-09-17
CH464202A (en) 1968-10-31
DK112447B (en) 1968-12-16
DE1793561A1 (en) 1972-01-20
FI47100B (en) 1973-05-31
DK112238B (en) 1968-11-25
SE307133B (en) 1968-12-23
DE1695485A1 (en) 1971-04-15
FI47096B (en) 1973-05-31
FR1559559A (en) 1969-03-14
DE1695486A1 (en) 1971-04-15
FI47101B (en) 1973-05-31
SE302130B (en) 1968-07-08
CH557815A (en) 1975-01-15
CH466285A (en) 1968-12-15
CH489495A (en) 1970-04-30
CH464203A (en) 1968-10-31
FI46955C (en) 1973-08-10
DE1770116A1 (en) 1971-10-14
NL6400813A (en) 1964-08-03
GB1050731A (en)
DK112446B (en) 1968-12-16
FI47101C (en) 1973-09-10
SE302463B (en) 1968-07-22
BR6456479D0 (en) 1973-09-20
DE1695493A1 (en) 1971-04-01
GB1050739A (en)
CH457434A (en) 1968-06-15
AT277992B (en) 1970-01-12
GB1050736A (en)
DE1695487A1 (en) 1970-10-01
FI46955B (en) 1973-05-02
FI47099B (en) 1973-05-31
DE1695491A1 (en) 1971-04-15
DK109334C (en) 1968-04-16
CH466289A (en) 1968-12-15
GB1050732A (en)
DE1695484A1 (en) 1971-04-15
SE302133B (en) 1968-07-08
DE1695492A1 (en) 1971-04-01
GB1050728A (en)
CH466288A (en) 1968-12-15
CH457437A (en) 1968-06-15
DK112239B (en) 1968-11-25
GB1050729A (en)
CH466287A (en) 1968-12-15
DE1695490A1 (en) 1971-04-15
DE1695489A1 (en) 1970-08-13
CH466290A (en) 1968-12-15
GB1050735A (en)
DK111751B (en) 1968-10-07
SE302131B (en) 1968-07-08
CH466286A (en) 1968-12-15
DE1470059B1 (en) 1970-01-29
FI47185B (en) 1973-07-02
DE1770134A1 (en) 1971-09-30
GB1050730A (en)
CH466283A (en) 1968-12-15
SE304995B (en) 1968-10-14
FI47185C (en) 1973-10-10
DK112313B (en) 1968-12-02
SE302132B (en) 1968-07-08
CH466284A (en) 1968-12-15
FI47097C (en) 1973-09-10
DK112314B (en) 1968-12-02
SE320069B (en) 1970-02-02
GB1050733A (en)
FI47099C (en) 1973-09-10
CH457436A (en) 1968-06-15
SE320666B (en) 1970-02-16
BE643268A (en) 1964-07-31
FI47097B (en) 1973-05-31
GB1050737A (en)
DE1770132A1 (en) 1971-09-30
GB1050740A (en)
FI47100C (en) 1973-09-10
SE307948B (en) 1969-01-27
DK109562C (en) 1968-05-13
GB1050738A (en)
FI47098C (en) 1973-09-10
CH457435A (en) 1968-06-15
FI47098B (en) 1973-05-31
SE320367B (en) 1970-02-09
DK109514C (en) 1968-05-06
SE317975B (en) 1969-12-01
GB1050734A (en)
DK113501B (en) 1969-03-31
DE1770802A1 (en) 1972-02-17

Similar Documents

Publication Publication Date Title
DK114344B (en) Process for the preparation of therapeutically active alkyl or allyl esters of 6,7-dialkoxy-3-quinolinecarboxylic acids.
DK117827B (en) Analogous process for the preparation of therapeutically active carboxylic acid derivatives or esters, amides or salts thereof.
FI49497C (en) Process for the preparation of therapeutically active 1-phenoxy-2-3-alkylaminopropanes.
NL162060B (en) PROCESS FOR THE PREPARATION OF 2-SUBSTITUATED -3,3-DIMETHYLCYCLOPROPANECARBON ACIDS AND ESTERS THEREOF.
DK113645B (en) Process for the preparation of therapeutically effective indolyl-3-alkane-carboxylic acids.
DK119877B (en) Analogous process for the preparation of therapeutically active carboxylic acids or pharmaceutically acceptable salts thereof.
DK117635B (en) Analogous process for the preparation of therapeutically active 3- (piperazinoalkyl) -pyrazoles.
FI47096C (en) Process for the preparation of tert-butyl ester of therapeutically active alpha- (3-indolyl) lower aliphatic acids.
NL140236B (en) PROCESS FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE SULFAMYLANTRANILIC ACID DERIVATIVES.
FI49032C (en) Process for the preparation of therapeutically active 7-nitro-8-hydroxyquinoline esters.
FI41394C (en) Process for the preparation of therapeutically active N-substituted I-aminoindan derivatives
DK111959B (en) Process for the preparation of α (3-indolyl) alkanoic acids.
FI47189C (en) Process for the preparation of therapeutically active d-lysergic acid-N-phenylpiperazides.
NL146781C (en) PROCESS FOR THE PREPARATION OF ACETIC ACID.
FI47661C (en) Process for the preparation of therapeutically active benzofuran derivatives.
FI43994C (en) Process for the preparation of new therapeutically active 1,2-diaryl-4-alkyl-3,5-dioxopyrazolidines
FI48736C (en) Process for the preparation of 2-benzimidazolecarbamic acid esters.
NL148875B (en) PROCESS FOR THE PREPARATION OF N-ARYL-ALPHA-AMINOCARBON ACID ESTERS.
DK114832B (en) Process for the preparation of therapeutically active 3β-hydroxy-16α-alkyl-δ <4> -pregnant derivatives or esters thereof.
FI48078C (en) Analogous process for the preparation of new therapeutically active pyridylamides of aliphatic carboxylic acids
CA665540A (en) PROCESS FOR PREPARING ESTERS OF 17.alpha.-HYDROXY PROGESTERONE
FI49712C (en) Process for the preparation of therapeutically active prostanoic acid derivatives.
DK118716B (en) Analogous process for the preparation of therapeutically active 6α-methyl-16-methylene-Δ <4> -ostrene-17β-oils or esters thereof.
FI44610C (en) Process for the preparation of novel, therapeutically active substitutes for pyridylamides of unsaturated fatty acids.
FI40636C (en) Process for the preparation of therapeutically active aliphatic hydroxydiamines